Basic information about the COVID-19 vaccines based on World Health Organization data (available here). There are four main approaches to...
COVID-19 vaccine race
read more
How to make gene optimization for expression in Escherichia coli a piece of cake
What you will read about: our opinion about gene optimization in E.coli. The redesign of coding sequences using predetermined parameters...
Biotherapeutic development: how we optimized CHO transient transfection for protein and antibody production
In order to provide timely production of your recombinant proteins and monoclonal antibodies, the GTP team has developed CHO-based...
Why you should consider the production of your recombinant protein with Pichia pastoris?
Pichia pastoris has some key advantages that make it a system of choice for the production of certain types of protein. Brief history of...
GTP Technology adds trained Biosafety Officer to expert team
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety...
Which platform & partner for CHO cell line development?
Recent advances in mammalian cell line development and discussion of the criteria a biotech company should consider when starting its cell...
Everything you always wanted to know about Antibody Humanisation
What is antibody humanisation and what are the main differences between chimeric, humanised and fully human antibodies? An overview of...
Developing new CHO cell lines using lentiviral vectors for therapeutic proteins
A hint: it's not only about science. When looking to develop a competitive CHO biomanufacturing platform, lentiviral technology seems a...
